Raymond James & Associates Brainsway Ltd. Transaction History

Raymond James & Associates

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	BUY	$3.53 - $6.9 $48,117 - $94,053	13,631 Added 108.18%	26,231 $95,000
Q4 2021 Feb 08, 2022	BUY	$7.09 - $8.7 $89,334 - $109,619	12,600 New	12,600 $97,000
Q3 2020 Nov 04, 2020	SELL	$5.52 - $8.0 $102,119 - $148,000	-18,500 Closed	0 $0
Q1 2020 Apr 21, 2020	SELL	$5.23 - $12.31 $52,300 - $123,100	-10,000 Reduced 35.09%	18,500 $147,000
Q4 2019 Feb 12, 2020	BUY	$8.3 - $10.83 $83,000 - $108,300	10,000 Added 54.05%	28,500 $278,000
Q3 2019 Nov 07, 2019	BUY	$8.55 - $10.8 $158,175 - $199,800	18,500 New	18,500 $169,000

3.28M

Ticker BWAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 16,519,200
Market Cap $153M
Description
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addictio...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.